Inventor

David T. Hung

Inventor
Belmont, CA, US

Overview

48→
Patents
1995–2016
Patent span
Human necessities
Primary field (CPC A)

Patents· 48 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
A61BDiagnosis17%
C07DHeterocyclic compounds16%
A61KPreparations for medical, dental or toiletry purposes15%
A61MDevices for introducing media into, or onto, the body9%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
G01RMeasuring electric variables3%
A61NElectrotherapy2%
G01DMeasuring not specially adapted for a specific variable2%
PatentTitleYear
9,481,676'Azepino[4,5-B]indoles and methods of use'20169,469,641'Pyrido[3,4-B]indoles and methods of use'20169,468,718'Means and method for detecting free flow in an infusion line'20169,458,155'Pyrido[4,3-b]indoles containing rigid moieties'20169,409,910'Azepino[4,5-B]indoles and methods of use'20169,260,429'Pyrido[3,4-B]indoles and methods of use'20169,181,240'Tetracyclic compounds'20159,115,137'2,3,4,5-tetrahydro-1H-pyrido[4,3-B]indole compounds and methods of use thereof'20159,096,591'Tetracyclic compounds'20159,051,314'Bridged heterocyclic compounds and methods of use'20159,034,869'Bridged heterocyclic compounds and methods of use'20159,034,880'Tetracyclic compounds'20158,999,977'Bridged heterocyclic compounds and methods of use'20158,999,978'Tetracyclic compounds'20158,906,925'Pyrido[4,3-B]indoles containing rigid moieties'20148,907,097'Pyrido[4,3-b]indoles containing rigid moieties'20148,569,287'Azepino[4,5-B]indoles and methods of use'20138,546,381'Bridged heterocyclic compounds and methods of use'20138,338,447'Pyrido[3,4-B]indoles and methods of use'20128,338,408'Tetracyclic compounds'20128,178,493'Method for inducing angiogenesis in a heart of a patient'20127,628,765'Increasing retrievable cells from a breast duct'20097,531,511'Method for inducing angiogenesis or vascular perfusion in the myocardium comprising administering FGF-2'20097,405,045'Identification of viral agents in breast ducts and antiviral therapy therefore'20087,384,418'Methods and devices for delivery of agents to breast milk ducts'20087,204,829'Apparatus, methods and kits for simultaneous delivery of a substance to multiple breast milk ducts'20077,132,232'Identification of viral agents in breast ducts and antiviral therapy therefore'20067,029,462'Apparatus, methods and kits for simultaneous delivery of a substance to multiple breast milk ducts'20066,712,816'Methods and systems for treating breast tissue'20046,689,070'Devices, methods and systems for collecting material from a breast duct'20046,642,009'Isolated ductal fluid sample'20036,642,010'Identifying, monitoring, and treating women for breast precancer or cancer'20036,638,727'Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer'20036,629,936'Method and kits for differentiating breast ducts for cancer risk status'20036,610,484'Identifying material from a breast duct'20036,589,998'Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue'20036,585,706'Apparatus, methods and kits for simultaneous delivery of a substance to multiple breast milk ducts'20036,494,859'Methods using pressure to obtain fluids and cellular material from breast ducts'20026,413,228'Devices, methods and systems for collecting material from a breast duct'20026,398,765'Apparatus, methods and kits for simultaneous delivery of a substance to multiple breast milk ducts'20026,391,026'Methods and systems for treating breast tissue'20026,328,709'Devices and methods to identify ductal orifices during nipple aspiration'20016,314,315'Ductal orifice identification by characteristic electrical signal'20015,902,582'Use of TFPI inhibitor for treatment of cancer'19995,807,255'Positioning device for producing controlled movement of the cervical spine'19985,520,181'Positioning device for producing movement in the shoulder'19965,445,152'Kinematic device for producing precise incremental flexing of the knee'19955,442,858'Automated angle encoder system for MRI apparatus'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2016Based in Palo Alto, CA, US· patent location history
1999Based in San Francisco, CA, US· patent location history
2001–2012Based in Belmont, CA, US· patent location history
2003–2004Patents assigned to CYTYC HEALTH CORP (9)· patent assignee history
2006–2009Patents assigned to CYTYC CORP (6)· patent assignee history
2009–2016Based in Redwood City, CA, US· patent location history
2012–2016Patents assigned to MEDIVATION TECHNOLOGIES INC (19)· patent assignee history
2012–2015Patents assigned to HUNG DAVID T (7)· patent assignee history
2012–2015Patents assigned to CHAKRAVARTY SARVAJIT (6)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MEDIVATION TECHNOLOGIES INC192012–2016
CYTYC HEALTH CORP92003–2004
HUNG DAVID Tself72012–2015
CHAKRAVARTY SARVAJIT62012–2015
CYTYC CORP62006–2009
Locations
LocationPatentsSpan
Belmont, California, US222001–2012
Redwood City, California, US202009–2016
Palo Alto, California, US51995–2016
San Francisco, California, US11999